William McGarvey, MD
Foot and Ankle Surgery · Katy, TXNPI 1679544308
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $3,035,023 of the $3,506,890 with a category attached, or 86.5%. Stryker accounts for 98.2% of it on its own, with 28 other manufacturers making up the rest. Among foot and ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 534 payments — averaging $6567.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3.4M
- Extremity Medical$52K
- Treace Medical Concepts, Inc.$4K
- Medinc Of Texas$2K
- Alafair Biosciences, Inc.$694
- Medshape, Inc.$510
- plus $4K from 23 others
Across 40 payments — averaging $341.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$14K
Across 2 payments — averaging $416.67 each. An ownership or investment interest held by the physician or an immediate family member.
- Extremity Medical$833
What the payments were for
- Royalty or licence$3,035,02387%
- Consulting fees$387,34911%
- Speaking & faculty fees$22,7591%
- Travel & lodging$44,9371%
- Food & beverage$15,5390%
- Education$1,2850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 431 | $3,444,638 |
| Extremity Medical | 38 | $51,723 |
| Treace Medical Concepts, Inc. | 9 | $3,571 |
| Medinc Of Texas | 8 | $1,812 |
| Alafair Biosciences, Inc. | 4 | $694 |
| Medshape, Inc. | 5 | $510 |
| Innovation Technologies Inc | 4 | $403 |
| Zimmer Biomet | 4 | $381 |
| Paragon 28, Inc. | 3 | $343 |
| Smith+Nephew | 5 | $341 |
| Linvatec Corporation | 2 | $323 |
| In2bones USA, LLC | 2 | $275 |
| Sanara Medtech Inc. | 1 | $210 |
| Restor3d, Inc. | 1 | $209 |
| Ossio Inc | 1 | $198 |
| Johnson & Johnson | 2 | $185 |
| Trilliant Surgical LLC. | 1 | $141 |
| Arthrex | 1 | $140 |
| Nevro Corp. | 1 | $130 |
| Bone Support Inc. | 1 | $116 |
| Exactech, Inc. | 1 | $110 |
| Amgen | 1 | $98 |
| Medline Industries LP | 1 | $91 |
| Voom Medical Devices, Inc. | 1 | $89 |
| Osteocentric Technologies, Inc. | 1 | $57 |
| Kerecis Limited | 1 | $36 |
| Ossur Americas, Inc. | 2 | $28 |
| Vertex | 1 | $21 |
| Urgo Medical North America, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVISION$3,024,167
- INFINITY$66,325
- PROPHECY$47,866
- ORTHOLOC$24,643
- R&D Foot and Ankle$22,793
- IO FiX$21,885
- STAR$19,107
- PROstep$14,623
- VARIAX$13,425
- FIXOS$12,121
- OMEGA$11,751
- AXSOS$10,828
- Lapidus$10,000
- Joint prep$8,747
- PRIME SERIES$5,752
- INBONE$4,282
- Lapiplasty System$3,088
- INFINITY ADAPTIS$2,170
- CITREFIX$1,451
- Lapidus Instruments$1,168
How this compares
$3,506,890 in reported general payments places this provider in the 95th percentile of 684 foot and ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 157 | $2,088 |
| Cephalexin | 131 | $970 |
| Pregabalin | 12 | $832 |
| Gabapentin | 33 | $354 |
| Methylprednisolone | 44 | $215 |
| Promethazine Hcl | 40 | $210 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $184 |
| Tramadol Hcl | 25 | $98 |
| Meloxicam | 27 | $80 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $46 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Katy
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
- Vinod PanchbhaviGalveston$389K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.